🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dickran Kazandjian

University of Miami

ORCID: 0000-0002-6593-0917

Also affiliated with Sylvester Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma”.

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3971

N/A

1.3DataRank · unranked

45 citations

Elizabeth Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde +29 more

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0834

N/A

0.700DataRank · unranked

105 citations

Flora Mulkey, Emma Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab +9 more

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0210

N/A

0.516DataRank · unranked

16 citations

Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis‐Pistofidis, Bachisio Ziccheddu +14 more

Dose Escalation of ISB 1442, a Novel CD38 Biparatopic x CD47 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma

Blood(2024)10.1182/blood-2024-209952

N/A

0.104DataRank · unranked

1 citations

Hang Quach, Phoebe Joy Ho, Andrew Spencer, Mark A. Schroeder, Peter Tan +12 more

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

Nature Communications(2022)10.1038/s41467-022-33142-x

N/A

0DataRank · unranked

26 citations

Arnold Bolomsky, Thomas Oellerich, Ping Chen, Michele Ceribelli, Björn Häupl +21 more

T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2113532

N/A

0DataRank · unranked

18 citations

Andrew S. Kowalski, Ola Landgren, Dickran Kazandjian

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)

npj Precision Oncology(2022)10.1038/s41698-022-00315-2

N/A

0DataRank · unranked

18 citations

Sana Chaudhry, Tulasigeri M. Totiger, Robert Diaz, Evan R. Roberts, Skye Montoya +14 more

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma

Nature Communications(2023)10.1038/s41467-023-40966-8

N/A

0DataRank · unranked

39 citations

Francesco Maura, Edgar Gonzalez‐Kozlova, J. Javier Díaz-Mejía, Ping Luo, Yong Zhang +18 more

Extreme body mass index and survival in newly diagnosed multiple myeloma patients

Blood Cancer Journal(2023)10.1038/s41408-022-00782-7

N/A

0DataRank · unranked

23 citations

Karissa Whiting, Sean M. Devlin, Rachel Ershler, Bindu Kanapuru, David Jungpa Lee +14 more

Genomic Profiling to Contextualize the Results of Intervention for High-Risk Smoldering Myeloma

medRxiv(2023)10.1101/2023.08.30.23294483

N/A

0DataRank · unranked

1 citations

Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis‐Pistofidis, Bachisio Ziccheddu +14 more

Precision radiolabeled B-cell maturation nanobody for targeted PET imaging and radioligand therapy of disseminated multiple myeloma

Theranostics(2025)10.7150/thno.126920

N/A

0DataRank · unranked

0 citations

Colleen P. Olkowski, Falguni Basuli, Jianfeng Shi, Ryan M. Young, Dickran Kazandjian +5 more

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program

Discover Oncology(2025)10.1007/s12672-025-02433-2

N/A

0DataRank · unranked

0 citations

Maria Badikyan, Marina Konopleva, Alvaro J. Alencar, Arusyak Ivanyan, Carolyn Owen +34 more

The role of high‐dose melphalan with autologous stem‐cell transplant in multiple myeloma: is it time for a paradigm shift?

British Journal of Haematology(2020)10.1111/bjh.16764

N/A

0DataRank · unranked

33 citations

Clifton C. Mo, Ola Landgren, Paul G. Richardson, Dickran Kazandjian

Diagnostic performance of 18F‐FDG‐PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward

British Journal of Haematology(2020)10.1111/bjh.17088

N/A

0DataRank · unranked

7 citations

Esther Mena, Candis Morrison, Alexander Dew, Peter L. Choyke, Liza Lindenberg +2 more

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.28.470260

N/A

0DataRank · unranked

1 citations

Thomas Oellerich, Ping Chen, Arnold Bolomsky, Michele Ceribelli, Björn Häupl +21 more